Stock Price
74.30
Daily Change
-0.06 -0.08%
Monthly
1.50%
Yearly
-21.59%
Q2 Forecast
72.12

Symrise reported EUR2.08B in Operating Expenses for its fiscal semester ending in December of 2024.





Operating Expenses Change Date
Avient USD 739.4M 31M Sep/2025
Chemours USD 1.33B 71M Dec/2025
Corteva USD 3.1B 217M Dec/2025
Covestro EUR 3.24B 5.46B Dec/2025
Symrise EUR 2.08B 118.33M Dec/2024
Victrex GBP 123.9M 200K Dec/2025